Merck Tbk Cash Flow Conversion Efficiency

Latest as of June 2025: 0.166x

Merck Tbk cash flow conversion efficiency. Based on the latest financial reports, Merck Tbk (MERK) has a cash flow conversion efficiency ratio of 0.166x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp137.63 Billion ≈ $8.06 Million USD) by net assets (Rp829.78 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Merck Tbk (2000–2024)

Cash flow conversion efficiency of Merck Tbk from 2000 to 2024. This chart illustrates how Merck Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MERK stock price for real-time trading data and today's change.

Merck Tbk Cash Flow Conversion Ratio Explained

Merck Tbk cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Merck Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Merck Tbk ranked by their cash flow conversion efficiency. Also see Merck Tbk market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Resources Connection Inc
NASDAQ:RGP
0.014x
Apontis Pharma AG
XETRA:APPH
-0.061x
Nasmedia Co. Ltd
KQ:089600
-0.051x
Reworld Media
PA:ALREW
0.128x
Epileds Technologies Inc
TW:4956
0.021x
Onward Technologies Limited
NSE:ONWARDTEC
0.138x
Gan Ltd
NASDAQ:GAN
-0.074x
Fortune Mate Indonesia Tbk
JK:FMII
-0.004x

Annual Cash Flow Conversion Efficiency for Merck Tbk (2000–2024)

The table below shows the annual cash flow conversion efficiency of Merck Tbk from 2000 to 2024. Review MERK free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp807.27 Billion
≈ $47.30 Million
Rp55.71 Billion
≈ $3.26 Million
0.069x -73.06%
2023-12-31 Rp795.88 Billion
≈ $46.64 Million
Rp203.87 Billion
≈ $11.95 Million
0.256x +75.83%
2022-12-31 Rp757.24 Billion
≈ $44.37 Million
Rp110.32 Billion
≈ $6.46 Million
0.146x -41.31%
2021-12-31 Rp684.04 Billion
≈ $40.08 Million
Rp169.81 Billion
≈ $9.95 Million
0.248x +111.30%
2020-12-31 Rp612.68 Billion
≈ $35.90 Million
Rp71.98 Billion
≈ $4.22 Million
0.117x +133.10%
2019-12-31 Rp594.01 Billion
≈ $34.81 Million
Rp-210.84 Billion
≈ $-12.35 Million
-0.355x -208.88%
2018-12-31 Rp518.28 Billion
≈ $30.37 Million
Rp168.96 Billion
≈ $9.90 Million
0.326x +54.43%
2017-12-31 Rp615.44 Billion
≈ $36.06 Million
Rp129.92 Billion
≈ $7.61 Million
0.211x +180.84%
2016-12-31 Rp582.67 Billion
≈ $34.14 Million
Rp43.80 Billion
≈ $2.57 Million
0.075x -77.85%
2015-12-31 Rp473.54 Billion
≈ $27.75 Million
Rp160.70 Billion
≈ $9.42 Million
0.339x -19.30%
2014-12-31 Rp553.69 Billion
≈ $32.44 Million
Rp232.83 Billion
≈ $13.64 Million
0.420x +61.82%
2013-12-31 Rp512.22 Billion
≈ $30.01 Million
Rp133.10 Billion
≈ $7.80 Million
0.260x +22.49%
2012-12-31 Rp416.74 Billion
≈ $24.42 Million
Rp88.40 Billion
≈ $5.18 Million
0.212x -32.90%
2011-12-31 Rp494.18 Billion
≈ $28.96 Million
Rp156.23 Billion
≈ $9.15 Million
0.316x -28.09%
2010-12-31 Rp363.02 Billion
≈ $21.27 Million
Rp159.58 Billion
≈ $9.35 Million
0.440x +91.60%
2009-12-31 Rp354.18 Billion
≈ $20.75 Million
Rp81.26 Billion
≈ $4.76 Million
0.229x -27.60%
2008-12-31 Rp327.32 Billion
≈ $19.18 Million
Rp103.73 Billion
≈ $6.08 Million
0.317x +28.61%
2007-12-31 Rp280.23 Billion
≈ $16.42 Million
Rp69.05 Billion
≈ $4.05 Million
0.246x -36.50%
2006-12-31 Rp235.58 Billion
≈ $13.80 Million
Rp91.42 Billion
≈ $5.36 Million
0.388x +79.51%
2005-12-31 Rp180.38 Billion
≈ $10.57 Million
Rp38.99 Billion
≈ $2.28 Million
0.216x -39.90%
2004-12-31 Rp154.04 Billion
≈ $9.03 Million
Rp55.40 Billion
≈ $3.25 Million
0.360x -11.02%
2003-12-31 Rp159.51 Billion
≈ $9.35 Million
Rp64.48 Billion
≈ $3.78 Million
0.404x +113.28%
2002-12-31 Rp149.25 Billion
≈ $8.75 Million
Rp28.29 Billion
≈ $1.66 Million
0.190x -38.74%
2001-12-31 Rp127.49 Billion
≈ $7.47 Million
Rp39.44 Billion
≈ $2.31 Million
0.309x -24.27%
2000-12-31 Rp96.86 Billion
≈ $5.68 Million
Rp39.57 Billion
≈ $2.32 Million
0.409x --

About Merck Tbk

JK:MERK Indonesia Drug Manufacturers - Specialty & Generic
Market Cap
$91.62 Million
Rp1.56 Trillion IDR
Market Cap Rank
#19300 Global
#311 in Indonesia
Share Price
Rp3490.00
Change (1 day)
-1.13%
52-Week Range
Rp3020.00 - Rp4380.00
All Time High
Rp4843.89
About

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an… Read more